Celanese (CE)
(Real Time Quote from BATS)
$132.74 USD
-1.25 (-0.93%)
Updated Jul 9, 2024 01:22 PM ET
3-Hold of 5 3
B Value D Growth D Momentum D VGM
Price, Consensus and EPS Surprise
CE 132.74 -1.25(-0.93%)
Will CE be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CE
Here's Why You Should Hold Onto Celanese (CE) Stock for Now
Zacks Industry Outlook Highlights PPG Industries, Celanese and Axalta Coating
CE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Celanese (CE) is a Strong Value Stock
Here's Why Celanese (CE) is a Strong Value Stock
3 Chemical Specialty Stocks to Escape Industry Headwinds
Other News for CE
Celanese to Hold Second Quarter Earnings Conference Call on August 2, 2024
Demystifying Celanese: Insights From 15 Analyst Reviews
Celanese price target lowered by $15 at Wells Fargo, here's why
Celanese price target lowered by $19 at Citi, here's why
Wells Fargo updated its Signature Picks, with Vertex Pharma and AvalonBay as adds